IL33 and COVID-19: Analyses of patients in stage II of COVID-19 revealed a moderate positive correlation between Gal-1 and IL-1β (p = 0.004) and strong positive correlations between Gal-1 and IL-23 (p = 0.001) and IL-33 (p = 0.001) (Table 3).